Bladder Management for Patients with Myelodysplasia

Surgical Clinics of North America

Volumn 86, Issue 2, 2006, Pages 515-523

  Carr, Michael C ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN A; BULKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; EPHEDRINE; PHENOXYBENZAMINE;

ARNOLD CHIARI MALFORMATION; BALLOON CATHETER; BLADDER DISEASE; BLADDER EMPTYING; BLADDER FUNCTION; BLADDER SURGERY; BRAIN VENTRICLE PERITONEUM SHUNT; CATHETERIZATION; COHORT ANALYSIS; DEVELOPMENTAL DISORDER; ECHOGRAPHY; HUMAN; MENINGOMYELOCELE; MYELODYSPLASIA; NERVOUS SYSTEM INJURY; PATIENT COMPLIANCE; PEDIATRICS; PLASTIC SURGERY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SPINAL CORD; SURGICAL TECHNIQUE; URETHRA; URINARY TRACT INFECTION;

CHILD; HUMANS; NEURAL TUBE DEFECTS; NEUROMUSCULAR AGENTS; TREATMENT OUTCOME; URINARY BLADDER DISEASES; UROLOGIC SURGICAL PROCEDURES;

EID: 33645857976     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2006.01.003     Document Type: Review

References (25)

1. Lapides J., Diokno A.C., Silber S.J., et al. Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107 (1971) 458
2. Bauer S.B. Pediatric neurology. In: Krane R.J., and Siroky M.B. (Eds). Clinical neuro-urology (1979), Little, Brown and Company, Boston 279
3. Barson A.J. The vertebral level of termination of the spinal cord during normal and abnormal development. J Anat 106 (1970) 489
4. Johnston J.H., and Farkas A. Congenital neuropathic bladder: practicalities and possibilities of conservative management. Urology 5 (1975) 729
5. McGuire E.J., Woodside J.R., Bordon T.A., et al. Prognostic value of urodynamic testing in myelodysplasia patients. J Urol 126 (1981) 205
6. Webster G.D., et al. The urological evaluation and management of patients with myelodysplasia. Br J Urol 58 (1986) 261
7. Bauer S.B., Hallett M., Khoshbin S., et al. Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 252 (1984) 650
8. Adzick N.S., and Walsh D.S. Myelomeningocele: prenatal diagnosis, pathophysiology and management. Semin Pediatr Surg 12 3 (2003) 168
9. Rintoul N.E., Sutton L.N., Hubbard A.M., et al. A new look at myelomeningoceles: functional level, vertebral level, shunting and the implications for fetal intervention. Pediatrics 109 3 (2002) 409
10. Ghoniem G.M., Bloom D.A., McGuire E.J., et al. Bladder compliance in myelomeningocele children. J Urol 141 (1989) 1404
11. van Gool J.D., et al. Detrusor sphincter dyssynergia in children with myelomeningocele: a prospective study. Z Kinderchir 37 (1982) 148
12. Bauer S.B., and Spindel M.R. The changing neurological lesion in myelodysplasia. JAMA 258 (1987) 1630
13. Hopps C.V., and Kropp K.A. Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close follow-up. J Urol 169 1 (2003) 305
14. Goessl C., Knispel H.H., Fiedler U., et al. Urodynamic effects of oral Oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia. Urol 51 (1998) 94
15. Bloom D.A., Knechtel J.M., and McGuire E.J. Urethral dilation improves bladder compliance in children with myelomeningocele and high leak point pressures. J Urol 144 (1990) 430
16. Park J.M., McGuire E.J., Koo H.P., et al. External urethral sphincter dilation for the management of high risk myelomeningocele: 15-year experience. J Urol 165 (2001) 2383
17. Schulte-Baukloh H., Michael T., Schobert J., et al. Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urol 59 (2002) 325
18. Riccabona M., Koen M., Schindler M., et al. Botulinum-a toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171 (2004) 845
19. Kass E.J., and Koff S.A. Bladder augmentation in the pediatric neuropathic bladder. J Urol 129 (1983) 552
20. Misseri R., Casale A.J., Cain M.P., et al. Alternative uses of dextranomer/hyaluronic acid copolymer: the efficacy of bladder neck injection for urinary incontinence. J Urol 174 4 Pt 2 (2005) 1691
21. Dik P., Klijn A.J., van Gool J.D., et al. Transvaginal sling suspension of bladder neck in female patients with neurogenic sphincter incontinence. J Urol 170 2 Pt 1 (2003) 580 [discussion: p. 581]
22. Kropp K.A. Bladder neck reconstruction in children. Urol Clin North Am 26 3 (1999) 661
23. Pippi Salle J.L. Surgical management of urinary incontinence in children with neurogenic sphincteric incompetence. J Urol 164 5 (2000) 1668
24. Gonzalez R., Merino F.G., and Vaughn M. Long-term results of the artificial urinary sphincter in male patients with neurogenic bladder. J Urol 154 2 Pt 2 (1995) 769
25. Koff S.A., Gigax M.R., and Jayanthi V.R. Nocturnal bladder emptying: a simple technique for reversing urinary tract deterioration in children with neurogenic bladder. J Urol 174 4 Pt 2 (2005) 1629